Skip to main content
10 DECEMBER, 2021

bioMérieux – Increased outlook for full-year 2021

bioMérieux, a world leader in the field of in vitro diagnostics, today released its adjusted outlook for full-year 2021.
  • In light of stronger than expected respiratory panels sales in Q4, full-year 2021 net sales are now expected to grow above 8% at constant exchange rates and scope of consolidation (previously: 4% to 7%) and contributive operating income before non-recurring items to be above €780 million (previously: above €700 million).
  • As a reminder, this 2021 exceptional performance is not projectable beyond 2021.

Filename
biomerieux_pr_outlook_2021.pdf
Size
196 KB
Format
application/pdf